According to the Bank’s website, the existing building complex of the Theageneio Cancer Treatment Hospital is one of the four cancer treatment hospitals in Greece, and the only one in northern Greece. The existing hospital's catchment area are the regions of West Macedonia, Central Macedonia, and East Macedonia & Thrace. Its original design, half a century ago, was sufficient to cover the needs of the time, however, the continuous increase of neoplasms, as well as the constant improvement of therapeutic interventions applied to oncology patients have made the hospital inadequate from a building point of view.

The existing hospital currently accommodates 361 beds. It treats 52,000 patients on average annually and performs 5,500 surgeries and 40,000 chemotherapy treatments on an annual basis. Furthermore, 110,000 patients attend the regular outpatient clinics and perform 2,000,000 various laboratory tests in a year.The existing hospital faces increased demand in a limited space, suboptimal patient flow and outdated infrastructure. More specifically:

It currently operates within a spatial (building-plot) framework which is considered inadequate due to the serious insufficiency of the available total building area, but also, in terms of suitability and age of the infrastructure. The intensive care unit is limited with no expansion capacity in the current building. The internal flow of patients is suboptimal due to the 11-floor setup with the various wards and buildings. The old and inefficient infrastructure requires constant repairs and maintenance. It is located within the central fabric of the city creating problems of access and connectivity. This causes traffic congestion, as well as discomfort for the patients and families (approximately 1,000 people visit the hospital per day) when commuting to the hospital. Traffic also makes logistics of the hospital difficult.

It currently operates within a spatial (building-plot) framework which is considered inadequate due to the serious insufficiency of the available total building area, but also, in terms of suitability and age of the infrastructure.

This project of strategic importance envisages the relocation and operation of an oncology complex dedicated to providing a multitude of services required for the diagnosis, treatment and hospitalisation of patients suffering from neoplastic diseases. The primary objective is to address the escalating demand for neoplasm treatment while simultaneously enhancing therapeutic interventions for patients.

The proposed facility is designed to accommodate 425 beds, ensuring more efficient services and the utilization of modern treatment methodologies. Clinical and non-clinical services will be provided in the new hospital. All clinical services will be provided by the public sector, while some non-clinical services will be provided by competent external suppliers. The private sector will create the infrastructure and provide the facility management for the infrastructure supporting the clinical services.
The construction site is strategically located within the former military camp “Karatasiou”, currently a Metropolitan Park, outside the city of Thessaloniki. The Metropolitan Park permits the establishment of supra-local importance facilities that serve public utility functions.

Investment type and amount not available at the time of disclosure.

No contacts available at the time of disclosure.

ACCESS TO INFORMATION

You can request information by emailing: accessinfo@ebrd.com or by using this electronic form: https://www.ebrd.com/eform/information-request

ACCOUNTABILITY MECHANISM OF EBRD

The Project Complaint Mechanism (PCM) is the independent complaint mechanism and fact-finding body for people who have been or are likely to be adversely affected by an European Bank for Reconstruction and Development (EBRD)-financed project. If you submit a complaint to the PCM, it may assess compliance with EBRD's own policies and procedures to prevent harm to the environment or communities or it may assist you in resolving the problem that led to the complaint through a dialogue with those implementing the project. Additionally, the PCM has the authority to recommend a project be suspended in the event that harm is imminent.

You can contact the PCM at: pcm@ebrd.com or you can submit a complaint online using an online form at: http://www.ebrd.com/eform/pcm/complaint_form?language=en

You can learn more about the PCM and how to file a complaint at: http://www.ebrd.com/work-with-us/project-finance/project-complaint-mechanism.html